Neoadjuvant Immunotherapy for T4 dMMR Colon Cancer
Conditions: Colon Cancer; Mismatch Repair Deficiency; Immunotherapy Interventions: Drug: Camrelizumab Sponsors: Peking Union Medical College Hospital Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Colon Cancer | Colorectal Cancer | Gastroschisis Repair | Hospitals | Immunotherapy | Neoadjuvant Therapy | Research